Back to results
US 12,577,583 B2Granted
DNA sequence modification-based gene drive
AssigneeCalifornia Institute of Technology
InventorsBruce A. Hay, Georg Oberhofer, Tobin William Ivy
Life of this patent
Estimating the term…
Abstract
Described herein are embodiments relating to manipulation of populations and sex ratio in populations through DNA sequence modifications.
Claims11
A composition comprising two vectors:
- a first vector comprising:
- a first sequence encoding a first component of a DNA sequence modifying complex, wherein the first component of the DNA sequence modifying complex is a nuclease, wherein the nuclease is Cas9 nuclease;
- a second sequence encoding a second component of the DNA sequence modifying complex, wherein the second component of the DNA sequence modifying complex is a guide RNA, wherein the guide RNA enables the Cas9 nuclease to target specific sequences within the essential gene;
- a first promoter operably linked to the first sequence encoding the first component of the DNA sequence modifying complex, wherein the first promoter comprises at least one of a germline promoter, a male specific germline promoter, a female specific germline promoter, a cell-type specific promoter, a tissue-specific promoter, a ubiquitous promoter, a promoter activated at a specific stage of mitosis, a promoter activated at a specific stage of meiosis, a viral promoter or prokaryotic promoter;
- and
- a second promoter operably linked to the second sequence encoding the second component of the DNA sequence modifying complex, wherein the second promoter comprises at least one of a germline promoter, a male specific germline promoter, a female specific germline promoter, a cell-type specific promoter, a tissue-specific promoter, a ubiquitous promoter, a promoter activated at a specific stage of mitosis, a promoter activated at a specific stage of meiosis, a viral promoter or prokaryotic promoter;
- wherein the DNA sequence modifying complex is configured to induce one or more sequence modifications in an endogenous copy of an essential gene;
- a second vector comprising:
- a rescue transgene sequence, wherein the rescue transgene is either a recoded copy of the essential gene or is a gene of unrelated sequence, wherein the rescue transgene encodes a protein that is functionally equivalent to a protein encoded by the essential gene;
- and
- a rescue transgene promoter operably linked to the rescue transgene sequence, wherein the rescue transgene promoter comprises at least one of a endogenous promoter for the essential gene, germline promoter, a male specific germline promoter, a female specific germline promoter, a cell-type specific promoter, a tissue-specific promoter, a ubiquitous promoter, a promoter activated at a specific stage of mitosis, a promoter activated at a specific stage of meiosis, a viral promoter or prokaryotic promoter,
- wherein the composition comprising two vectors is configured for reversibly modifying a population of organisms.
9 more elements
Dependencies are inferred from the claim text.